Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report released on Tuesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Price Performance

Shares of NASDAQ AEMD opened at $0.37 on Tuesday. The firm has a market capitalization of $5.16 million, a PE ratio of -0.13 and a beta of 1.79. Aethlon Medical has a 1-year low of $0.24 and a 1-year high of $2.35. The business’s fifty day moving average price is $0.39 and its two-hundred day moving average price is $0.42.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.